No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
148 |
4. Check minimum number of eventsNone |
148 |
5. Include endpointsNone |
148 |
6. Filter based on genotype QC (FinnGen only) |
135 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Osteosarcoma, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of bone and articular cartilage, including Hilmo
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
- Malignant neoplasm, including Hilmo
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 135 | 59 | 76 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 37.12 | 29.16 | 43.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 139
- Matched controls
- 1390
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
86.8
74
*
C40.21
ICD-10 Finland
Osteosarcoma of the long bones of the lower extremity
+∞
61.0
54
*
9180/3-C40.2
ICD-O-3
Osteosarcoma, NOS, of long bones of lower limb and associated joints
+∞
58.5
52
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
174.2
54.4
54
5
N02AA05
ATC
oxycodone; systemic
11.2
42.4
59
86
A03FA01
ATC
metoclopramide; systemic, rectal
10.6
39.4
56
83
H02AB02
ATC
dexamethasone; systemic
120.1
34.6
36
*
JN4BD
NOMESCO Finland
Extensive body CT
15.7
34.5
33
27
GD1AD
NOMESCO Finland
Thorax CT examination
14.1
32.4
33
30
JN4AD
NOMESCO Finland
Body CT examination
13.6
31.7
33
31
L03AA02
ATC
filgrastim; parenteral
347.5
28.9
28
*
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
28.1
26
*
A04AA01
ATC
ondansetron; systemic, rectal
35.4
27.4
35
13
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
90.7
27.0
29
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
25.8
24
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
24.7
23
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
35.7
24.4
31
11
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.4
24.4
28
30
C40.20
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity without histology
+∞
23.6
22
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
23.6
23.1
33
18
NF3AA
NOMESCO Finland
Femur X-ray examination
28.1
22.9
31
14
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.2
22.8
52
122
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
+∞
22.5
21
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
22.5
21
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.7
22.1
95
381
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
43.0
20.7
25
7
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
8.0
20.1
31
48
L03AA13
ATC
pegfilgrastim; parenteral
231.6
20.1
20
*
ZXE20
NOMESCO Finland
More than three and less than five hours
6.1
19.2
41
89
B01AB05
ATC
enoxaparin; parenteral
4.9
19.2
66
216
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
18.1
17
*
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
+∞
18.1
17
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
7.7
17.4
27
42
WX408
NOMESCO Finland
General anesthesy, balanced
4.7
17.3
59
190
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
17.0
16
*
C40.01
ICD-10 Finland
Osteosarcoma of the scapula and the long bones of the upper extremity
+∞
17.0
16
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
17.0
16
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
17.0
16
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
54.5
16.5
19
*
R4110
NOMESCO Finland
Physiotherapy
4.4
16.1
61
211
C40.91
ICD-10 Finland
Osteosarcoma in unspecified locations in the bones and articular cartilage of the extremities
+∞
15.9
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
179.3
15.8
16
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.2
15.6
75
306
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
5.5
15.6
36
83
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
51.3
15.5
18
*
WW500
NOMESCO Finland
Blood transfusion
19.4
15.4
23
14
Z51.5
ICD-10 Finland
Palliative care
18.1
15.0
23
15
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.8
14
*
NG4AA
NOMESCO Finland
Lower leg X-ray examination
14.2
14.8
25
21
A04AA02
ATC
granisetron; systemic, transdermal
166.8
14.8
15
*
ZXE10
NOMESCO Finland
More than one and less than three hours
4.0
14.5
67
263
N03AX16
ATC
[U] pregabalin
4.2
14.3
52
172
WX402
NOMESCO Finland
General anaesthesia
4.3
13.9
47
147
NGB30
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis
+∞
13.8
13
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.5
13.1
29
64
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
12.7
12
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
142.3
12.7
13
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.1
12.5
30
71
ZXA05
NOMESCO Finland
Left side
3.9
12.3
50
177
ZXE00
NOMESCO Finland
One hour or less
3.4
11.6
74
347
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
11.6
11
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
11.6
11
*
C40.11
ICD-10 Finland
Osteosarcoma of the short bones of the upper extremity
+∞
11.6
11
*
1707A
ICD-9 Finland
Malignant neoplasm of bone and articular cartilage, Long bones of lower limb[ALARAAJAN PITKIEN LUIDEN SYÖPÄ,OSTEOSARCOMA]
+∞
11.6
11
*
115
Kela drug reimbursment
Breast cancer
+∞
11.6
11
*
XX3DW
NOMESCO Finland
Time consuming IT work
11.6
11.5
21
21
B01AB10
ATC
tinzaparin; parenteral
5.5
10.9
23
48
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.8
10.8
41
137
ZXE30
NOMESCO Finland
More than five and less than seven hours
10.1
10.7
21
24
WX302
NOMESCO Finland
Thoracal epidural anesthesy
17.9
10.6
16
10
TPX15
NOMESCO Finland
Removal of vascular injection port
118.6
10.6
11
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
10.5
10
*
C41.41
ICD-10 Finland
Osteosarcoma of the pelvic bones, sacrum and coccyx
+∞
10.5
10
*
9180/3-C40.0
ICD-O-3
Osteosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
10.5
10
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
+∞
10.5
10
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
10.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.5
10
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.5
10.4
49
189
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
5.1
10.3
24
55
ZXE40
NOMESCO Finland
More than seven and less than nine hours
18.5
10.1
15
9
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.4
10.1
29
79
J04AB02
ATC
rifampicin; systemic
59.2
9.8
11
*
JN4CD
NOMESCO Finland
Very extensive body CT
32.6
9.6
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
107.0
9.5
10
*
C40.00
ICD-10 Finland
Malignant tumor of the scapula and the long bones of the upper extremity without histology
+∞
9.5
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.5
9
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.5
9
*
9101
FHL
Bone biopsy
+∞
9.5
9
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
9.5
9
*
17071
ICD-8 Finland
Malignant neoplasm of bone, Lower limb, long bones
+∞
9.5
9
*
ZX120
NOMESCO Finland
Intravenous
5.2
9.4
21
46
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
17.1
9.2
14
9
ZZA00
NOMESCO Finland
Split skin graft
17.1
9.2
14
9
ZXA00
NOMESCO Finland
Right side
3.2
9.2
48
195
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.2
8.8
26
72
R4120
NOMESCO Finland
Occupational therapy
5.2
8.6
19
41
ZXD10
NOMESCO Finland
Scheduled procedure
2.9
8.6
64
316
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
Z89.6
ICD-10 Finland
Acquired absence of leg above knee
+∞
8.4
8
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
8.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
C41.4
ICD-10 Finland
Malignant neoplasm: Pelvic bones, sacrum and coccyx
+∞
8.4
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
8.4
8
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
9.9
8.3
16
18
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
11.1
8.3
15
15
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.9
8.2
20
33
WX002
NOMESCO Finland
Sedation and analgesia
3.4
8.0
34
121
WZC30
NOMESCO Finland
Teaching
3.7
8.0
29
93
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
47.7
7.8
9
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
47.7
7.8
9
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
47.7
7.8
9
*
R50.9
ICD-10 Finland
Fever, unspecified
3.2
7.8
36
135
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.2
7.7
18
28
NB6AA
NOMESCO Finland
Humerus X-ray examination
14.4
7.5
12
9
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
84.4
7.5
8
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.0
7.4
17
38
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.5
7.4
19
47
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
7.4
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.4
7
*
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
+∞
7.4
7
*
C41.91
ICD-10 Finland
Osteosarcoma in unspecified localization in bone and articular cartilage
+∞
7.4
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.4
7
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
7.4
7
*
C40.22
ICD-10 Finland
Chondrosarcoma of the long bones of the lower extremity
+∞
7.4
7
*
A79
ICPC
Malignancy NOS
+∞
7.4
7
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
+∞
7.4
7
*
C40.81
ICD-10 Finland
Overall osteosarcoma of the extremities' bones and articular cartilage
+∞
7.4
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.4
7
*
C40.10
ICD-10 Finland
Malignant tumor of the upper limb's short bones without histology
+∞
7.4
7
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
7.4
7
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
7.4
7
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
+∞
7.4
7
*
C40.31
ICD-10 Finland
Osteosarcoma of the short bones of the lower extremity
+∞
7.4
7
*
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
21.4
7.2
10
5
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
7.1
45
201
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.5
6.8
14
18
B01AB04
ATC
dalteparin; parenteral
7.2
6.5
15
23
HA1AA
NOMESCO Finland
X-ray mammography
15.3
6.5
10
7
NFQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of hip or femur
73.1
6.5
7
*
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
73.1
6.5
7
*
WF002
NOMESCO Finland
Radical radiotherapy
73.1
6.5
7
*
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
10.0
6.4
12
13
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
19.1
6.3
9
5
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
19.1
6.3
9
5
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
28.1
6.3
8
*
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
+∞
6.3
6
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
+∞
6.3
6
*
GDB10
NOMESCO Finland
Wedge resection of lung
+∞
6.3
6
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
NFA20
NOMESCO Finland
Exploration of hip joint or femur
+∞
6.3
6
*
NF3AD
NOMESCO Finland
Femur CT
+∞
6.3
6
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
6.1
6.2
16
29
J01FF01
ATC
clindamycin; systemic
2.6
6.2
45
214
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
6.9
6.0
14
22
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
17
0
+∞
18.11
32.5
0.0
0.37
—
umol/l
—
17
0
95
450
4.51
16.16
25.4
8.1
1.20
1.21
mmol/l
0.71
90
418
42
113
4.89
15.18
14.7
8.6
5.47
5.12
kpa
1.15
42
108
42
113
4.89
15.18
14.7
8.6
13.97
11.92
kpa
1.43
42
108
23
36
7.46
14.61
27.3
16.3
1.14
1.49
mg/l
1.83
23
31
30
64
5.70
14.07
19.3
12.1
0.84
0.66
%
1.29
30
64
87
417
3.90
13.86
10.8
4.9
35.16
36.52
g/l
1.43
82
391
30
66
5.52
13.59
19.2
11.8
1.20
1.42
%
0.54
30
66
62
240
3.86
13.55
7.9
2.1
—
—
—
0
0
96
507
3.89
12.88
28.8
8.2
1.21
1.21
mmol/l
0.29
84
457
47
160
3.93
12.21
2.4
1.6
—
—
—
0
0
43
143
3.91
11.48
29.3
9.1
104.74
104.27
mmol/l
0.28
43
143
38
119
4.02
11.00
2.5
1.5
—
—
—
0
0
39
127
3.88
10.66
2.4
1.5
—
—
—
0
0
87
469
3.29
10.53
6.1
2.5
—
—
estimate
—
0
0
31
87
4.30
10.36
47.2
17.0
25.40
24.49
mmol/l
0.86
31
87
101
632
3.19
8.79
31.4
7.9
3.83
4.20
e9/l
0.86
90
539
20
46
4.91
8.46
3.8
1.8
28.71
2.50
ug/l
0.49
15
34
27
82
3.85
8.01
3.1
3.6
0.20
0.22
g/l
0.45
27
75
15
19
8.70
7.32
2.1
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
28
6.76
7.03
15.7
3.2
0.28
0.29
iu/ml
—
10
17
12
11
11.80
6.94
1.4
1.3
—
—
—
0
0
10
6
17.80
6.85
1.3
1.2
—
—
—
0
0
15
23
7.17
6.54
1.7
1.3
—
—
—
0
0
66
375
2.45
6.22
4.1
3.9
—
—
—
0
0
23
75
3.48
6.10
2.8
1.8
89.58
75.91
ml/min/173m2
0.68
12
23
36
157
2.74
5.82
4.3
3.1
14.32
13.36
umol/l
0.27
36
146
25
89
3.21
5.77
5.6
2.6
—
—
—
0
0
14
24
6.36
5.70
1.6
1.3
—
—
—
0
0
55
305
2.33
5.30
3.1
3.7
0.37
0.27
e6/l
0.30
42
209
14
27
5.64
5.24
1.9
1.5
—
—
—
0
0
9
10
9.52
4.86
1.1
1.0
—
—
—
0
0
19
64
3.28
4.77
1.7
1.6
—
—
—
0
0
9
12
7.93
4.43
1.1
1.2
—
—
—
0
0
16
51
3.42
4.36
2.2
1.4
—
—
—
0
0
8
9
9.34
4.34
1.1
1.2
—
—
—
0
0
8
10
8.40
4.12
1.6
1.5
—
—
—
0
0
14
39
3.87
3.83
6.5
2.8
219.36
183.82
%
0.83
14
39
12
32
4.00
3.48
1.9
2.8
—
—
—
0
0
50
312
1.94
3.29
7.5
3.2
916.20
1234.19
ng/l
0.59
45
261
10
25
4.23
3.15
1.5
1.1
—
—
—
0
0
7
13
5.61
2.90
1.4
2.1
11.00
10.38
mmol/l
—
7
13
6
9
6.90
2.89
8.7
3.4
6.67
11.89
%
—
6
9
5
6
8.58
2.77
3.0
5.8
108.80
105.67
%
—
5
6
59
408
1.78
2.71
4.2
3.7
16.72
38.38
ng/l
1.86
45
272
40
246
1.88
2.68
6.9
1.8
2.06
1.22
mg/l
0.80
35
190
23
116
2.18
2.64
12.9
6.5
—
—
—
0
0
5
7
7.35
2.57
1.4
1.7
—
—
—
0
0
8
21
3.98
2.50
1.4
1.1
—
—
—
0
0
120
1042
2.11
2.41
29.3
11.0
89.75
86.28
ml/min/173m2
0.79
115
938
5
8
6.43
2.39
10.2
4.1
—
—
—
0
0
6
13
4.77
2.29
1.3
1.8
—
—
—
0
0
5
9
5.71
2.23
1.6
1.1
—
—
—
0
0
5
9
5.71
2.23
1.6
1.1
—
—
—
0
0
5
9
5.71
2.23
1.6
1.1
—
—
—
0
0
7
19
3.82
2.18
2.6
2.7
—
—
—
0
0
7
19
3.82
2.18
1.3
1.1
—
—
—
0
0
6
14
4.43
2.17
1.2
1.0
—
—
—
0
0
5
10
5.14
2.09
1.6
1.2
—
—
—
0
0
7
20
3.63
2.08
1.6
1.1
—
—
—
0
0
6
17
3.64
1.86
1.7
1.1
—
—
—
0
0
6
17
3.64
1.86
1.7
1.1
—
—
—
0
0
8
29
2.86
1.82
1.9
1.5
—
—
—
0
0
8
29
2.86
1.82
2.1
1.8
—
—
—
0
0
63
487
1.54
1.69
3.3
3.0
74.75
73.82
nmol/l
0.09
56
432
101
871
1.58
1.60
5.1
3.8
15.11
14.74
pmol/l
0.70
95
802
13
64
2.14
1.60
2.2
1.5
—
—
—
0
0
40
283
1.58
1.57
1.6
1.6
20.00
18.89
nmol/l
0.16
35
242
127
1166
2.03
1.56
39.4
12.3
29.50
23.37
mg/l
1.15
116
905
73
590
1.50
1.55
5.5
3.8
0.00
0.00
estimate
-0.00
14
112
7
27
2.67
1.53
1.6
1.7
—
—
—
0
0
12
59
2.13
1.48
54.6
7.5
0.60
0.59
%
0.04
12
59
6
22
2.80
1.45
1.3
1.5
0.11
0.74
nmol/l
—
6
13
12
60
2.09
1.43
54.6
7.4
1.40
1.11
%
0.88
12
60
71
583
1.45
1.33
5.5
3.8
0.00
0.00
estimate
-0.00
14
111
5
19
2.69
1.22
1.4
1.3
—
—
—
0
0
14
226
0.58
1.13
1.9
1.3
203.88
28.35
iu/ml
—
5
73
16
97
1.73
1.12
2.2
2.4
1.64
0.20
e6/l
0.78
16
92
18
113
1.68
1.12
3.1
2.3
334.06
383.87
nmol/l
0.72
18
105
31
223
1.50
1.12
4.1
3.4
49.00
354.68
ng/l
1.48
26
163
14
225
0.58
1.12
1.7
2.4
—
—
—
0
0
71
599
1.38
1.07
5.5
3.8
0.00
0.00
estimate
-0.00
14
105
28
199
1.51
1.07
2.8
3.2
0.76
1.07
e6/l
0.28
14
107
41
317
1.42
1.02
6.7
3.7
0.00
0.00
estimate
-0.00
13
107
13
207
0.59
1.00
1.8
2.2
—
—
—
0
0
13
207
0.59
1.00
1.2
1.4
0.90
8.80
u/ml
—
6
83
0
28
0.00
0.99
0.0
1.9
—
—
—
0
0
6
28
2.19
0.92
2.2
1.8
—
—
—
0
0
10
57
1.81
0.86
7.1
3.7
5.04
4.92
pmol/l
—
10
51
96
1044
0.74
0.84
6.3
6.0
38.24
38.92
mmol/mol
0.32
90
993
0
26
0.00
0.79
0.0
1.6
—
52.82
—
0
26
0
26
0.00
0.79
0.0
1.2
—
2.38
—
0
5
114
1063
1.40
0.77
5.8
4.6
2.08
1.86
mu/l
1.02
108
982
24
181
1.39
0.69
1.4
1.8
392.69
433.96
pmol/l
0.45
16
160
5
27
1.88
0.69
1.0
1.3
—
—
—
0
0
5
27
1.88
0.69
1.0
1.0
—
—
—
0
0
24
186
1.35
0.59
3.0
3.3
3.36
2.73
e6/l
—
9
95
6
35
1.75
0.58
1.0
1.3
—
—
—
0
0
5
89
0.55
0.58
1.2
1.2
—
184.67
—
0
34
6
36
1.70
0.57
1.0
1.1
—
—
—
0
0
6
36
1.70
0.57
1.0
1.1
—
—
—
0
0
109
1146
0.77
0.54
5.1
5.1
2.73
2.71
mmol/l
0.11
102
1081
51
448
1.22
0.48
6.2
3.5
0.00
0.00
estimate
-0.00
13
93
52
460
1.21
0.46
1.8
1.9
95.24
92.83
pmol/l
0.10
24
238
0
15
0.00
0.41
0.0
1.1
—
193.79
—
0
15
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
17
0.00
0.41
0.0
1.7
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
109
1134
0.82
0.37
5.0
4.6
4.61
4.57
mmol/l
0.15
102
1075
32
281
1.18
0.30
1.4
1.7
—
—
—
0
0
109
1126
0.85
0.27
4.9
4.5
1.43
1.42
mmol/l
0.07
102
1061
29
328
0.85
0.27
1.1
1.6
1.91
2.02
u/ml
—
7
79
5
39
1.29
0.23
1.2
1.2
—
—
—
0
0
8
105
0.75
0.22
1.5
2.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
104
1064
0.91
0.14
4.5
3.9
1.24
1.28
mmol/l
0.22
97
995
106
1082
0.91
0.13
4.6
4.3
5.62
5.83
mmol/l
1.54
98
998
5
43
1.17
0.10
1.4
1.6
0.15
0.21
g/l
—
5
43
5
44
1.14
0.10
1.0
1.3
—
15.20
—
0
7
5
44
1.14
0.10
1.0
1.5
—
0.10
—
0
7
29
308
0.93
0.09
2.8
3.7
26.20
23.52
%
0.41
16
136
6
55
1.09
0.09
1.0
1.1
1.43
1.55
g/l
—
6
55
6
55
1.09
0.09
1.0
1.1
0.92
0.93
g/l
—
6
55
7
67
1.05
0.08
1.0
1.3
—
—
—
0
0
9
88
1.02
0.07
2.1
3.1
3.03
6.42
ug/l
—
9
77
29
276
1.06
0.06
6.6
3.6
1.01
1.02
kg/l
1.90
20
166
34
328
1.05
0.04
5.7
3.0
0.00
0.00
estimate
-0.00
11
92
84
846
0.98
0.00
3.7
3.5
—
—
—
0
0
16
156
1.03
0.00
1.6
1.6
—
—
—
0
0
22
219
1.01
0.00
2.0
2.7
0.69
0.76
ug/l
0.18
15
129
35
345
1.02
0.00
3.5
4.2
11.72
8.45
mg/mmol
0.16
23
243
8
87
0.91
0.00
1.5
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
7.33
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
16.07
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
40.40
—
0
7
0
5
0.00
-0.00
0.0
1.8
—
216.80
—
0
5
8
79
1.01
-0.00
1.3
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OSTEOSARCOMA_WIDE – Osteosarcoma, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).